DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,686,770 | +1.0% | 135,779 | -2.3% | 0.33% | +6.1% |
| Q2 2023 | $33,340,320 | -3.1% | 138,918 | +1.8% | 0.31% | -9.4% |
| Q1 2023 | $34,396,907 | +139119.3% | 136,474 | +46.6% | 0.34% | -8.8% |
| Q4 2022 | $24,707 | -99.9% | 93,086 | +0.5% | 0.37% | -2.6% |
| Q3 2022 | $23,927,000 | +10.4% | 92,636 | +8.4% | 0.38% | +11.0% |
| Q2 2022 | $21,669,000 | -10.5% | 85,472 | +3.6% | 0.35% | +5.2% |
| Q1 2022 | $24,211,000 | -16.0% | 82,540 | -5.8% | 0.33% | -7.1% |
| Q4 2021 | $28,818,000 | -3.6% | 87,591 | -10.8% | 0.35% | -3.5% |
| Q3 2021 | $29,883,000 | +5.6% | 98,156 | -6.9% | 0.37% | +11.6% |
| Q2 2021 | $28,302,000 | +18.8% | 105,462 | -0.4% | 0.33% | +11.5% |
| Q1 2021 | $23,823,000 | -3.8% | 105,843 | -5.0% | 0.30% | -5.4% |
| Q4 2020 | $24,763,000 | -3.1% | 111,471 | -6.1% | 0.31% | -9.6% |
| Q3 2020 | $25,558,000 | +30.4% | 118,696 | +7.0% | 0.34% | +10.6% |
| Q2 2020 | $19,607,000 | +22.5% | 110,882 | -4.1% | 0.31% | +6.5% |
| Q1 2020 | $16,004,000 | -7.3% | 115,626 | +2.8% | 0.29% | +11.4% |
| Q4 2019 | $17,270,000 | +0.5% | 112,523 | -5.4% | 0.26% | -3.3% |
| Q3 2019 | $17,177,000 | -1.1% | 118,928 | -2.1% | 0.27% | +0.7% |
| Q2 2019 | $17,365,000 | +7.6% | 121,500 | -0.6% | 0.27% | +5.1% |
| Q1 2019 | $16,137,000 | +26.1% | 122,232 | -1.5% | 0.26% | +13.7% |
| Q4 2018 | $12,793,000 | -14.8% | 124,060 | -10.3% | 0.23% | +9.2% |
| Q3 2018 | $15,021,000 | +1.5% | 138,236 | -7.9% | 0.21% | +2.5% |
| Q2 2018 | $14,803,000 | -4.7% | 150,013 | -5.4% | 0.20% | -2.4% |
| Q1 2018 | $15,529,000 | +0.1% | 158,609 | -5.1% | 0.21% | +6.7% |
| Q4 2017 | $15,511,000 | +6.7% | 167,107 | -1.4% | 0.19% | +4.3% |
| Q3 2017 | $14,533,000 | +0.3% | 169,417 | -1.3% | 0.19% | -2.6% |
| Q2 2017 | $14,483,000 | -5.0% | 171,624 | -3.7% | 0.19% | -4.0% |
| Q1 2017 | $15,246,000 | +7.4% | 178,257 | -2.2% | 0.20% | +5.3% |
| Q4 2016 | $14,194,000 | -3.2% | 182,343 | -2.6% | 0.19% | -4.1% |
| Q3 2016 | $14,670,000 | -25.3% | 187,142 | -3.7% | 0.20% | -24.5% |
| Q2 2016 | $19,634,000 | +0.4% | 194,394 | -5.7% | 0.26% | +5.7% |
| Q1 2016 | $19,551,000 | +0.2% | 206,100 | -1.9% | 0.25% | +2.9% |
| Q4 2015 | $19,512,000 | +8.0% | 210,074 | -0.9% | 0.24% | +3.9% |
| Q3 2015 | $18,068,000 | -5.8% | 212,042 | -5.4% | 0.23% | +4.5% |
| Q2 2015 | $19,189,000 | -1.7% | 224,201 | -2.5% | 0.22% | +2.3% |
| Q1 2015 | $19,517,000 | -2.0% | 229,877 | -1.1% | 0.22% | -1.4% |
| Q4 2014 | $19,925,000 | +10.8% | 232,467 | -1.8% | 0.22% | +7.9% |
| Q3 2014 | $17,989,000 | -8.9% | 236,756 | -5.6% | 0.20% | -0.5% |
| Q2 2014 | $19,746,000 | -0.1% | 250,803 | -4.9% | 0.20% | 0.0% |
| Q1 2014 | $19,770,000 | -7.8% | 263,594 | -5.1% | 0.20% | -3.8% |
| Q4 2013 | $21,433,000 | +3.9% | 277,628 | -6.7% | 0.21% | 0.0% |
| Q3 2013 | $20,631,000 | +9.2% | 297,617 | -0.3% | 0.21% | +7.6% |
| Q2 2013 | $18,900,000 | -0.8% | 298,571 | -2.6% | 0.20% | -0.5% |
| Q1 2013 | $19,053,000 | – | 306,561 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |